The Association for Clinical Oncology (ASCO) along with other health care organizations sent a letter to U.S. Senate leadership to convey their opposition to an extension of mandatory Medicare sequestration as a pay-for in any infrastructure package. The letter urges lawmakers to reconsider the potential use of Medicare funds included in the bipartisan infrastructure framework.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
Members of Congress recently reintroduced the Cancer Drug Parity Act (H.R. 4385) in the U.S. House of Representatives. The bill would ensure patient cost sharing for oral and other self-administered anticancer drugs is no less favorable than for traditional intravenous (IV) medication administered in an office setting.
The Centers for Medicare & Medicaid Services (CMS) released its 2022 Hospital Outpatient Prospective Payment System (OPPS) proposed rule. Specific provisions that would impact the cancer care community are included here.
On July 13, 2021, the Centers for Medicare & Medicaid Services released its proposed rule for the 2022 Medicare Physician Fee Schedule and updates to the Quality Payment Program (QPP). The Association for Clinical Oncology (ASCO) is still analyzing the full proposal, but based on a preliminary analysis, key provisions for the cancer care community are included here.
Delegates from the Association for Clinical Oncology (ASCO) participated in a Special Meeting of the American Medical Association’s (AMA) House of Delegates (HOD), where the HOD voted to approve two ASCO-backed resolutions.
American Society of Clinical Oncology (ASCO) members who are practicing oncologists may have received emails inviting them to participate in the American Medical Association’s (AMA) Specialty Society Relative Value Scale (RVS) Update Committee (RUC) survey.
The Centers for Medicare & Medicaid Services (CMS) recently announced updates to the Merit-based Incentive Payment System (MIPS) under the Quality Payment Program (QPP). The agency reweighted the 2020 MIPS cost performance category, opened applications for the 2021 MIPS promoting interoperability performance category hardship and extreme and uncontrollable circumstances exceptions, and released MIPS Cost measure benchmarks.
The Association for Clinical Oncology (ASCO) submitted comments to a House Ways and Means Health Subcommittee hearing titled “Charting the Path Forward for Telehealth.” The comments convey ASCO’s views on how telehealth can better serve individuals with cancer and the oncology professionals who care for them.
The Centers for Medicare & Medicaid Services released part two of the Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Standards final rule.
The Centers for Medicare & Medicaid Services released the Fiscal Year (FY) 2022 Medicare Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Rates Proposed Rule. The proposed rule would update the Medicare fee-for-service payment rates and policies for inpatient hospitals and long-term care hospitals for FY 2022.
From April 12-16, U.S. members of the Association for Clinical Oncology (ASCO) participated in the 2021 ASCO Advocacy Summit, where 148 advocates from 44 states and the District of Columbia held 222 virtual meetings – the most ever held during an Advocacy Summit – with Members of Congress and staff to urge action on important policies to improve access to high-quality, equitable care for people with cancer.
UPDATE: On Tuesday, April 13, 2021, the House passed the Senate bill to extend the moratorium on the 2% Medicare sequestration cuts through the end of the calendar year. President Biden signed the bill into law on Wednesday, April 14, 2021. CMS has resumed processing claims.
Both chambers of the United States Congress recently passed separate bills to extend the temporary moratorium on the 2% sequestration cut to Medicare reimbursement. The moratorium is currently set to expire on March 31, 2021, and both bills would extend the moratorium until December 31, 2021. However, since the House and Senate legislation differ, further action is needed before the extension becomes law.
The Association for Clinical Oncology (ASCO) is holding its 2021 ASCO Advocacy Summit Week of Action from April 12-16. During the Week of Action, ASCO members can visit ASCO’s easy-to-use ACT Network to quickly and efficiently contact their lawmakers to urge them to take action on cancer policy priorities.
The Centers for Medicare & Medicaid Services (CMS) announced it will hold physicians harmless from Merit-based Incentive Payment System (MIPS) penalties due to the significant disruptions the COVID-19 public health emergency placed on physician practices’ performance in 2020.
The American Society of Clinical Oncology’s (ASCO) Road to Recovery Report: Learning from the COVID-19 Experience to Improve Clinical Research and Cancer Care, among other recommendations, calls for the U.S. Department of Health and Human Services (HHS) to establish a special enrollment period on the federal health insurance exchange, abandon plans that limit access to healthcare, and enact policies that enhance access to care for patients with cancer. ASCO applauds the Biden administration for its recent actions supporting policies that aim to promote and protect access to high-quality, equitable cancer care, as outlined in the “Road to Recovery” report.